TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19301514

Group type: EXPERIMENTAL
Intervention: Test Dentifrice (0.3% triclosan/2.0% PVM/MA copolymer/0.243% sodium fluoride in a 17% dual silica base)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control Dentifrice (0.243% sodium fluoride in a silica base)
Number of subjects: 94
Study: 17147088

Group type: EXPERIMENTAL
Intervention: Sodium Phosphate 40 milliliters the day before and the day of colonoscopy
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Senna 12 mg and Magnesium Sulphate 15 mg the day before colonoscopy
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Polyethylene Glycol-based solution of two litres plus 4 tablets of Bisacodyl the day before the exam
Number of subjects: 273
Study: 12681033

Group type: EXPERIMENTAL
Intervention: GyneFix
Number of subjects: 175

Group type: COMPARATOR
Intervention: Gyne-T380S
Number of subjects: 175
Study: 10720544

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF; 0.3 mg/mL 3 times a week) for 12 weeks
Number of subjects: 30
Study: 9192400

Group type: EXPERIMENTAL
Intervention: Nutrition and eating‐habit change followed by exercise (NE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise followed by nutrition and eating‐habit change (EN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Information control (INFO)
Number of subjects: 0
Study: 1337322

Group type: COMPARATOR
Intervention: Molsidomine (16 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3990295

Group type: EXPERIMENTAL
Intervention: Expected alcohol consumption during low-attention demand task
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Actual alcohol consumption during high-attention demand task
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sober condition during both cognitive tasks
Number of subjects: 32
Study: 31256126

Group type: EXPERIMENTAL
Intervention: D‐CHESS (Dementia‐Comprehensive Health Enhancement Support System) for 6 months
Number of subjects: 31

Group type: COMPARATOR
Intervention: Caregiving book (Control)
Number of subjects: 31
Study: 29889245

Group type: EXPERIMENTAL
Intervention: 10 min Brief Advice
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Brief Advice plus 20 min of brief Counselling
Number of subjects: 205

Group type: COMPARATOR
Intervention: Screening only (Controls)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Routinely collected re-offending data
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Indices of deprivation data
Number of subjects: 205
Study: 27317303

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CsA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: VIVIT
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 4‐aminopyridine (4‐AP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 24773615

Group type: EXPERIMENTAL
Intervention: Tribulus terrestris extract (7.5 mg/day)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 23021433

Group type: COMPARATOR
Intervention: Daily oral glutamine (0.5 g kg(‐1) d(‐1)) for 4 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Acute oral glutamine (0.5 g kg(‐1) d(‐1)) for 5 hours
Number of subjects: 30
Study: 19908093

Group type: EXPERIMENTAL
Intervention: TACE with DC Bead loaded with doxorubicin
Number of subjects: 212

Group type: COMPARATOR
Intervention: cTACE with doxorubicin
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: TACE with DC Bead
Number of subjects: 212
Study: 18505468

Group type: EXPERIMENTAL
Intervention: Exercise training (ET) for 3 months
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 124
Study: 16054408

Group type: EXPERIMENTAL
Intervention: Pain prevalence among women
Number of subjects: 3616

Group type: EXPERIMENTAL
Intervention: Socio-economic factors (e.g. financial strain)
Number of subjects: 3616

Group type: EXPERIMENTAL
Intervention: Psychosocial work conditions (i.e. work strain and social support)
Number of subjects: 3616

Group type: EXPERIMENTAL
Intervention: Socio-economic/psychosocial work conditions
Number of subjects: 3616
Study: 12848286

Group type: EXPERIMENTAL
Intervention: High-DHA eggs (135 mg DHA/egg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ordinary eggs (18 mg DHA/egg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-DHA eggs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ordinary eggs
Number of subjects: 0
Study: 11200150

Group type: EXPERIMENTAL
Intervention: Irinotecan and 5-FU/leucovorin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-FU/leucovorin
Number of subjects: 0
Study: 9004188

Group type: EXPERIMENTAL
Intervention: Multi-segment absorption model for diclofenac sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional pharmacokinetic method (first-order absorption)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-segment absorption models
Number of subjects: 0
Study: 1480873

Group type: EXPERIMENTAL
Intervention: Manual treatment of pelvic joint dysfunction
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo treatment (massage)
Number of subjects: 39
Study: 3758947

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (0.6 microgram) + Hepatitis B immune globulin (500 IU)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Hepatitis B vaccine only (0.6 microgram)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Booster inoculation (0.6 microgram)
Number of subjects: 175
Study: 29308823

Group type: EXPERIMENTAL
Intervention: Self-propelled particles (SPPs) with a constant force f
Number of subjects: 0
Study: 27803230

Group type: EXPERIMENTAL
Intervention: Percutaneous radiofrequency heat lesion (80oC during 60 seconds per level) applied to the medial branch of the primary dorsal ramus
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham procedure (same procedure without the radiofrequency lesion)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Graded activity physiotherapy programme (both groups received this)
Number of subjects: 60
Study: 24849077

Group type: EXPERIMENTAL
Intervention: Active treatment (self-measurement of pressure pain sensitivity followed by acupressure)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 213
Study: 22273342

Group type: EXPERIMENTAL
Intervention: Nurse-led cognitive behavioral group therapy once a week for 12 weeks
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Nurse-led cognitive behavioral group therapy
Number of subjects: 41
Study: 20382983

Group type: EXPERIMENTAL
Intervention: Endovascular repair
Number of subjects: 1252

Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 1252
Study: 17888042

Group type: EXPERIMENTAL
Intervention: Cystoscopic surveillance (CUS)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Microsatellite analysis (MA)
Number of subjects: 220
Study: 16015266

Group type: EXPERIMENTAL
Intervention: MN‐1 (n = 360)
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: MN‐2 (n = 374)
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Control (n = 366)
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: MN‐1
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: MN‐2
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: MN‐2 among anaemic women (30%)
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 2100
Study: 12534609

Group type: EXPERIMENTAL
Intervention: Valaciclovir 500 mg
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Valaciclovir 1000 mg
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Valaciclovir 2000 mg
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study: 10085416

Group type: EXPERIMENTAL
Intervention: RT-PCR for PSA
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: RT-PCR for PSMA
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: RT-PCR for Tyrosinase
Number of subjects: 106
Study: 7828385

Group type: EXPERIMENTAL
Intervention: 150 mg lifibrol for 4 weeks
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: 300 mg lifibrol for 4 weeks
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: 450 mg lifibrol for 4 weeks
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: 600 mg lifibrol for 4 weeks
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: 900 mg lifibrol for 4 weeks
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: 150 mg lifibrol for 12 weeks
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: 300 mg lifibrol for 12 weeks
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: 600 mg lifibrol for 12 weeks
Number of subjects: 491

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 491
Study: 2193858

Group type: EXPERIMENTAL
Intervention: Epidural steroid administration (50 mg Ultracortene‐H) with 2 mg morphine hydrochloride
Number of subjects: 95

Group type: COMPARATOR
Intervention: Epidural morphine hydrochloride without Ultracortene‐H
Number of subjects: 95
Study: 869108

Group type: EXPERIMENTAL
Intervention: Furazolidone
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Nimorazole
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 172
Study: 31825554

Group type: EXPERIMENTAL
Intervention: Mannitol
Number of subjects: 70

Group type: COMPARATOR
Intervention: PEG
Number of subjects: 70
Study: 30952223

Group type: EXPERIMENTAL
Intervention: Low SWAT + 25 Epoch SIOO
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Higher SWAT and lower SIOO
Number of subjects: 33
Study: 28682681

Group type: EXPERIMENTAL
Intervention: T-DM1
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: T-DM1 with ET
Number of subjects: 375

Group type: COMPARATOR
Intervention: Trastuzumab with ET
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Early responders
Number of subjects: 375
Study: 24754379

Group type: EXPERIMENTAL
Intervention: TDT 068
Number of subjects: 61

Group type: COMPARATOR
Intervention: Vehicle gel (control)
Number of subjects: 61
Study: 23662047

Group type: EXPERIMENTAL
Intervention: Olmesartan plus Azelnidipine (16 mg/day)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Olmesartan plus Amlodipine (5 mg/day)
Number of subjects: 52
Study: 21566261

Group type: EXPERIMENTAL
Intervention: 50 mg DHEA once daily
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 17698861

Group type: EXPERIMENTAL
Intervention: Bispectral Index (BIS) monitor with cut off values of 85, 70, and 55
Number of subjects: 85
Study: 16874601

Group type: EXPERIMENTAL
Intervention: Kangaroo Care (KC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Radiant Warmers (Control)
Number of subjects: 78
Study: 12641863

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 0
Study: 10980214

Group type: EXPERIMENTAL
Intervention: Fosinopril 20 mg/day
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Fosinopril 20 mg/day and Pravastatin 40 mg/day
Number of subjects: 864

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 864
Study: 9380271

Group type: EXPERIMENTAL
Intervention: OB-R immunoreactivity in the brain
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Western blotting analysis
Number of subjects: 35

Group type: COMPARATOR
Intervention: Comparison among groups (lean, obese, diabetic)
Number of subjects: 35
Study: 8407737

Group type: EXPERIMENTAL
Intervention: Revised package insert instructions (PII)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Original package insert instructions (PII)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Participants' perception of device usability
Number of subjects: 20
Study: 3490077

Group type: EXPERIMENTAL
Intervention: Periurethral injections of 10 ml 0.25% Bupivacaine, administered three times in 2-week intervals.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Acute maximum functional electrostimulation (AMFES) by vaginal electrode.
Number of subjects: 50
Study: 28339166

Group type: EXPERIMENTAL
Intervention: Avatrombopag; single doses under fasted and fed conditions.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avatrombopag; single dose.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Avatrombopag; comparison between Japanese and white subjects.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avatrombopag; general administration.
Number of subjects: 0
Study: 26981792

Group type: EXPERIMENTAL
Intervention: Double gloves
Number of subjects: 1536

Group type: COMPARATOR
Intervention: Single gloves
Number of subjects: 1536

Group type: COMPARATOR
Intervention: Unused control gloves
Number of subjects: 1536

Group type: EXPERIMENTAL
Intervention: Double gloves (total analysis)
Number of subjects: 1536

Group type: EXPERIMENTAL
Intervention: Inner gloves from double set
Number of subjects: 1536

Group type: EXPERIMENTAL
Intervention: Double gloves protection
Number of subjects: 1536
Study: 24710562

Group type: EXPERIMENTAL
Intervention: Extended care (EC) - fortnightly telephone counselling from a dietitian and exercise physiologist up to 100 days post transplantation
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Extended care (EC)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 37
Study: 22474954

Group type: EXPERIMENTAL
Intervention: Topical ointment prepared from Morinda citrifolia stem extract
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Morindicone and morinthone isolated from the extract
Number of subjects: 40
Study: 20837589

Group type: EXPERIMENTAL
Intervention: Stimulant monotherapy optimization with methylphenidate preparation (once-daily, triphasic release) and behavioral therapy
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Stimulant monotherapy
Number of subjects: 65
Study: 18394875

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate combination (SFC) 50microg/250microg + 1 placebo tablet
Number of subjects: 383

Group type: COMPARATOR
Intervention: Fluticasone propionate 250microg + 1 sustained release theophylline 200mg (SR-T+FP)
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate combination (SFC)
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 383
Study: 15944972

Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma (PRP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study: 12459668

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lung-protective strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups (entry)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups (36 hours)
Number of subjects: 0
Study: 10365356

Group type: EXPERIMENTAL
Intervention: Griffiths mental scales assessment for VLBW infants
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group of 60 infants assessed at a primary health care clinic
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Visual impairment assessment
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Hearing impairment assessment
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cerebral palsy assessment
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Functional handicap assessment
Number of subjects: 150
Study: 7706786

Group type: EXPERIMENTAL
Intervention: Synthetic verotoxin (VT, shiga‐like toxin) Pk‐trisaccharide receptor sequences attached to Chromosorb (Synsorb‐Pk)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synsorb‐Pk
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 1980979

Group type: EXPERIMENTAL
Intervention: Synthetic detergent preparation of pH 5.5
Number of subjects: 0

Group type: COMPARATOR
Intervention: Synthetic detergent preparation of pH 7.0
Number of subjects: 0
Study: 7234652

Group type: EXPERIMENTAL
Intervention: Aspirin therapy
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Indomethacin therapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: No treatment or minor analgesic therapy
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Aspirin and Indomethacin
Number of subjects: 58
Study: 30621789

Group type: EXPERIMENTAL
Intervention: Preconception lifestyle intervention
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Preconception lifestyle intervention (successful weight loss)
Number of subjects: 577

Group type: COMPARATOR
Intervention: Control group (prompt infertility treatment)
Number of subjects: 577
Study: 29972245

Group type: EXPERIMENTAL
Intervention: Healthy autogenous tooth roots (TR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cortical autogenous bone blocks (AB)
Number of subjects: 30
Study: 27254026

Group type: COMPARATOR
Intervention: Chemotherapy (Cisplatin and 5-fluorouracil)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (Cisplatin and 5-fluorouracil with concurrent radiotherapy 40 Gy)
Number of subjects: 31
Study: 24459063

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg
Number of subjects: 39

Group type: COMPARATOR
Intervention: glimepiride
Number of subjects: 39
Study: 22781570

Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 427
Study: 20453734

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 63
Study: 17627724

Group type: EXPERIMENTAL
Intervention: Integrated treatment protocol (ITP) with sildenafil and cognitive-behavior sex therapy (CBST) for the first 4 weeks, followed by continued ITP for the last 4 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sildenafil alone for the first 4 weeks, followed by addition of CBST for the last 4 weeks
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Integrated treatment protocol (ITP) with sildenafil and cognitive-behavior sex therapy (CBST) for the entire 8 weeks
Number of subjects: 53
Study: 15675894

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (1 g three times a day for 2 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 17
Study: 11849797

Group type: EXPERIMENTAL
Intervention: Amifostine (300 mg/m(2) administered 15-30 min before RT for 6-7.5 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional radiotherapy and carboplatin (90 mg/m(2) infusion once per week before RT)
Number of subjects: 50
Study: 9630382

Group type: EXPERIMENTAL
Intervention: Very low energy formula diet (2 MJ/d for 8 weeks)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Low-energy conventional diet (5 MJ/d for 17 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low fat diet ad libitum (n=16)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Energy-restricted diet (n=20)
Number of subjects: 36
Study: 7739031

Group type: EXPERIMENTAL
Intervention: Indirect range restriction in high-risk studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Range restriction approach
Number of subjects: 0
Study: 2971268

Group type: EXPERIMENTAL
Intervention: Doxycycline/benzylpenicillin procaine (DC + BP)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 64
Study: 29627608

Group type: EXPERIMENTAL
Intervention: Semicircular (SC) arm stroke technique
Number of subjects: 18

Group type: COMPARATOR
Intervention: Pump (P) arm stroke technique
Number of subjects: 18
Study: 25879690

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt (100 g/day) + placebo capsule
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Probiotic capsule + conventional yogurt (100 g/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional yogurt (100 g/day) + placebo capsule
Number of subjects: 70
Study: 23813627

Group type: EXPERIMENTAL
Intervention: Baseline C-reactive protein (CRP) levels
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: CRP >1 mg/L
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Complex bifurcation strategy
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Periprocedural myocardial necrosis
Number of subjects: 96
Study: 22241764

Group type: EXPERIMENTAL
Intervention: Vilanterol (VI) 25 μg
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Vilanterol (VI) 50 μg
Number of subjects: 602

Group type: COMPARATOR
Intervention: Vilanterol (VI) 3, 6.25, 12.5, 25, or 50 μg
Number of subjects: 602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 602
Study: 20308695

Group type: EXPERIMENTAL
Intervention: Carbohydrate sports drink (CHO)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 23
Study: 18494633

Group type: EXPERIMENTAL
Intervention: Chariker‐Jeter gauze‐based negative pressure systems (V1STA, Versatile‐1 and EZ‐Care; Smith & Nephew, Inc.) at -80 mmHg
Number of subjects: 30
Study: 15981670

Group type: EXPERIMENTAL
Intervention: Double-tract reconstruction group
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Large residual stomach
Number of subjects: 19

Group type: COMPARATOR
Intervention: Preoperative control group
Number of subjects: 19
Study: 15213209

Group type: EXPERIMENTAL
Intervention: Lifestyle changes (weight loss and increased physical activity)
Number of subjects: 110

Group type: COMPARATOR
Intervention: General information about healthy food choices and exercise (Control)
Number of subjects: 110
Study: 10670838

Group type: EXPERIMENTAL
Intervention: Group B (ISS >= 27)
Number of subjects: 43
Study: 9493699

Group type: EXPERIMENTAL
Intervention: Fixed combination of isradipine 2.5 mg plus spirapril 3 mg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Isradipine 5 mg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Spirapril 6 mg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Isradipine 2.5 mg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Spirapril 3 mg
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405
Study: 7687157

Group type: EXPERIMENTAL
Intervention: 10 mL of 23% saturated hypertonic saline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 30 mL of 7.5% hypertonic saline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 30 mL of 7.5% saline with 6% dextran 70
Number of subjects: 10